LON:CTEC ConvaTec Group (CTEC) Share Forecast, Price & News GBX 222.80 -0.20 (-0.09%) (As of 08:15 AM ET) Add Compare Share Share Today's Range 220.80▼ 224.2050-Day Range 205.80▼ 233.8052-Week Range 195.90▼ 257.87Volume1.10 million shsAverage Volume4.85 million shsMarket Capitalization£4.57 billionP/E Ratio7,426.67Dividend Yield2.24%Price TargetGBX 296 ProfileProfileAnalyst RatingsChartCompetitorsDividendInsider TradesHeadlinesProfileAnalyst RatingsChartCompetitorsDividendInsider TradesHeadlines ConvaTec Group MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside32.3% UpsideGBX 296 Price TargetShort InterestN/ADividend StrengthWeakBased on Four FactorsSustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.90 out of 5 stars 3.5 Analyst's Opinion Consensus RatingConvaTec Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of GBX 296, ConvaTec Group has a forecasted upside of 32.3% from its current price of GBX 223.80.Amount of Analyst CoverageConvaTec Group has only been the subject of 4 research reports in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for CTEC. Previous Next 0.8 Dividend Strength Dividend YieldConvaTec Group pays a meaningful dividend of 2.34%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthConvaTec Group does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of ConvaTec Group is 16,666.67%. Payout ratios above 75% are not desirable because they may not be sustainable. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CTEC. Previous Next 0.6 News and Social Media Coverage MarketBeat Follows1 people have added ConvaTec Group to their MarketBeat watchlist in the last 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, ConvaTec Group insiders have not sold or bought any company stock.Percentage Held by Insiders20.28% of the stock of ConvaTec Group is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions65.00% of the stock of ConvaTec Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of ConvaTec Group is 7,460.00, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 129.71.Price to Earnings Ratio vs. SectorThe P/E ratio of ConvaTec Group is 7,460.00, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 160.07.Price to Earnings Growth RatioConvaTec Group has a PEG Ratio of 1.97. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioConvaTec Group has a P/B Ratio of 2.80. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About ConvaTec Group (LON:CTEC) StockConvaTec Group PLC engages in the development, manufacture, and marketing of medical products and technologies worldwide. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence and critical care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as Parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. The company was founded in 1978 and is headquartered in Reading, the United Kingdom.Read More CTEC Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CTEC Stock News HeadlinesAugust 31, 2023 | finanznachrichten.deConvatec Group PLC: TR-1 Notification of Major HoldingsAugust 22, 2023 | finance.yahoo.comIs There An Opportunity With ConvaTec Group PLC's (LON:CTEC) 32% Undervaluation?September 22, 2023 | Wall Street Fundamentals (Ad)The "Plug and Play" Model Putting Online Giants to ShameWhile e-commerce has been undergoing a turbulent time, a "simple" model has grown 4X faster than Amazon over the last 3 years. Applying this model to high-margin, recession-resistant businesses has shown to be profitable. But that's just the beginning of explaining the 400+% growth - and potential - of this "diamond in the rough."August 4, 2023 | finance.yahoo.comConvaTec Group First Half 2023 Earnings: EPS Misses ExpectationsJuly 24, 2023 | finanznachrichten.deConvatec Group PLC: HOL-Holding(s) in CompanyJuly 10, 2023 | finance.yahoo.comConvaTec Group (LON:CTEC) Hasn't Managed To Accelerate Its ReturnsJune 9, 2023 | msn.comJP Morgan Cazenove Reiterates ConvaTec Group (LSE:CTEC) Overweight RecommendationJune 7, 2023 | finance.yahoo.comCTEC.L - ConvaTec Group PLCSeptember 22, 2023 | Edge On The Street (Ad)The Strategic Gold Play You Haven't Heard AboutExperts recommend adding gold to your portfolio, but in what form? Some savvy investors are now rejecting coins and mining stocks in favor of a unique gold investment alternative. It holds explosive growth potential similar to a junior gold stock -- but with less risk exposure. May 31, 2023 | uk.finance.yahoo.comConvatec Group PLC: Total Voting RightsMay 20, 2023 | msn.comBarclays Reiterates ConvaTec Group (LSE:CTEC) Overweight RecommendationMay 18, 2023 | uk.finance.yahoo.comConvatec Group PLC: Result of AGMApril 19, 2023 | marketwatch.com30 Technology's Clinically Validated Antimicrobial Nitric Oxide Platform Acquired by Convatec Group Plc for Several ApplicationsMarch 28, 2023 | uk.finance.yahoo.com2 cheap shares I’d buy as the FTSE 100 slidesMarch 26, 2023 | finance.yahoo.comConvaTec Group (LON:CTEC) shareholders YoY returns are lagging the company's 23% three-year earnings growthMarch 22, 2023 | markets.businessinsider.comConvatec Group PLC: Annual Report and Accounts 2022 and Notice of AGMMarch 2, 2023 | finance.yahoo.comFDA clears first placental extracellular matrix medical device for management of second-degree burnsJanuary 30, 2023 | finance.yahoo.comReturns On Capital At ConvaTec Group (LON:CTEC) Have StalledNovember 23, 2022 | finance.yahoo.comConvaTec Group Plc's (LON:CTEC) On An Uptrend But Financial Prospects Look Pretty Weak: Is The Stock Overpriced?October 17, 2022 | finance.yahoo.comInvesting in ConvaTec Group (LON:CTEC) three years ago would have delivered you a 20% gainSeptember 25, 2022 | markets.businessinsider.comConvatec Group PLC: Results of 2022 AGM Update StatementSeptember 25, 2022 | finance.yahoo.comConvaTec Group Plc's (LON:CTEC) Intrinsic Value Is Potentially 61% Above Its Share PriceSeptember 14, 2022 | finanznachrichten.deConvatec Group PLC: Scrip Dividend - Calculation PriceAugust 5, 2022 | finance.yahoo.comChris Gent fined £80,000 for trying his bestAugust 5, 2022 | finance.yahoo.comUK regulator fines Christopher Gent £80,000 for disclosing inside informationJune 16, 2022 | finance.yahoo.comIs ConvaTec Group Plc's (LON:CTEC) Stock Price Struggling As A Result Of Its Mixed Financials?May 16, 2022 | uk.news.yahoo.comWhat lies in store for the ConvaTec share price?See More Headlines Receive CTEC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ConvaTec Group and its competitors with MarketBeat's FREE daily newsletter. Email Address CTEC Company Calendar Last Earnings2/28/2020Ex-Dividend for 9/28 Dividend8/17/2023Today9/22/2023Dividend Payable9/28/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON Industry Medical Instruments & Supplies Sub-IndustryN/A SectorMedical Current SymbolLON:CTEC CUSIPN/A CIKN/A Webwww.convatecgroup.com Phone44 11 8952 8100FaxN/AEmployees10,000Year FoundedN/APrice Target and Rating Average Stock Price ForecastGBX 296 High Stock Price ForecastGBX 310 Low Stock Price ForecastGBX 280 Forecasted Upside/Downside+32.7%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)GBX 0.03 Trailing P/E Ratio7,433.33 Forward P/E Ratio18.28 P/E Growth1.97Net Income£70.30 million Net Margins3.37% Pretax MarginN/A Return on Equity4.38% Return on Assets4.58% Debt Debt-to-Equity Ratio90.12 Current Ratio1.70 Quick Ratio0.96 Sales & Book Value Annual Sales£2.08 billion Price / Sales2.20 Cash FlowGBX 13.11 per share Price / Cash Flow17.01 Book ValueGBX 80 per share Price / Book2.79Miscellaneous Outstanding Shares2,050,000,000Free FloatN/AMarket Cap£4.57 billion OptionableNot Optionable Beta0.63 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Karim Bitar (Age 58)CEO & Director Comp: $2.45MMr. Jonathan P. Mason (Age 59)Group CFO & Director Comp: $1.06MMr. John HallerExec. VP and Chief Quality & Operations OfficerDr. Divakar Ramakrishnan Ph.D.Exec. VP, Chief Technology Officer and Head of R&DMs. Kate PostansVP of Investor Relations & Corp. CommunicationsMs. Evelyn Douglas J.D.Exec. VP, Chief of Corp. Strategy & Bus. Devel. and Gen. CounselMs. Natalia KozminaExec. VP, Chief HR Officer & ESG StewardshipMr. Christian HoengaardSr. VP & GM - USAMs. Kjersti Grimsrud Biotechnology (Age 62)M.Sc., Pres & COO of Infusion Care Mr. Supratim Bose (Age 71)Pres & COO of Global Emerging Markets More ExecutivesKey CompetitorsDechra PharmaceuticalsLON:DPHHikma PharmaceuticalsLON:HIKMediclinic InternationalLON:MDCBTGLON:BTGAbcamLON:ABCView All CompetitorsInsidersKarim BitarSold 429,441 sharesTotal: £92.76 M ($216.00/share)Karim BitarSold 27,833 sharesTotal: £6.15 M ($221.00/share)Constantin CoussiosBought 9,861 shares on 9/30/2022Total: £2.02 M ($205.00/share)View All Insider Transactions CTEC Stock - Frequently Asked Questions Should I buy or sell ConvaTec Group stock right now? 5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ConvaTec Group in the last twelve months. There are currently 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" CTEC shares. View CTEC analyst ratings or view top-rated stocks. What is ConvaTec Group's stock price forecast for 2023? 5 brokers have issued 1 year price targets for ConvaTec Group's shares. Their CTEC share price forecasts range from GBX 280 to GBX 310. On average, they anticipate the company's share price to reach GBX 296 in the next twelve months. This suggests a possible upside of 32.7% from the stock's current price. View analysts price targets for CTEC or view top-rated stocks among Wall Street analysts. How have CTEC shares performed in 2023? ConvaTec Group's stock was trading at GBX 232.60 at the beginning of 2023. Since then, CTEC stock has decreased by 4.1% and is now trading at GBX 223. View the best growth stocks for 2023 here. How were ConvaTec Group's earnings last quarter? ConvaTec Group PLC (LON:CTEC) posted its quarterly earnings data on Friday, February, 28th. The company reported $12.00 EPS for the quarter, missing the consensus estimate of $12.70 by $0.70. ConvaTec Group had a net margin of 3.37% and a trailing twelve-month return on equity of 4.38%. How often does ConvaTec Group pay dividends? What is the dividend yield for ConvaTec Group? ConvaTec Group announced a dividend on Wednesday, August 2nd. Stockholders of record on Thursday, August 17th will be paid a dividend of GBX 0.02 per share on Thursday, September 28th. This represents a yield of 0.67%. The ex-dividend date is Thursday, August 17th. The official announcement can be viewed at this link. Read our dividend analysis for CTEC. Is ConvaTec Group a good dividend stock? ConvaTec Group (LON:CTEC) pays an annual dividend of GBX 5 per share and currently has a dividend yield of 2.34%. The dividend payout ratio is 16,666.67%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for CTEC. What other stocks do shareholders of ConvaTec Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other ConvaTec Group investors own include EnQuest (ENQ), Centamin (CEY), Oxford Biomedica (OXB), Bristol-Myers Squibb (BMY), Andalas Energy and Power (ADL), AFR.L (AFR), CBTX (CBTX), Genel Energy (GENL), Premier Oil (PMO) and Playtech (PTEC). What is ConvaTec Group's stock symbol? ConvaTec Group trades on the London Stock Exchange (LON) under the ticker symbol "CTEC." How do I buy shares of ConvaTec Group? Shares of CTEC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What is ConvaTec Group's stock price today? One share of CTEC stock can currently be purchased for approximately GBX 223. How much money does ConvaTec Group make? ConvaTec Group (LON:CTEC) has a market capitalization of £4.57 billion and generates £2.08 billion in revenue each year. The company earns £70.30 million in net income (profit) each year or GBX 0.03 on an earnings per share basis. How many employees does ConvaTec Group have? The company employs 10,000 workers across the globe. How can I contact ConvaTec Group? ConvaTec Group's mailing address is 3 Forbury Place Floor 7, 23 Forbury Road, ICKENHAM, RG1 3JH, United Kingdom. The official website for the company is www.convatecgroup.com. The company can be reached via phone at 44 11 8952 8100. This page (LON:CTEC) was last updated on 9/22/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ConvaTec Group PLC Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.